Drug General Information
Drug ID	D02UKE
Former ID	DNC014388
Drug Name	5-(pyridin-4-yl)-1,3,4-thiadiazole-2(3H)-thione
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530900]
Structure		Download 2D MOL 3D MOL
Formula	C7H5N3S2
Canonical SMILES	C1=CN=CC=C1C2=NNC(=S)S2
InChI	1S/C7H5N3S2/c11-7-10-9-6(12-7)5-1-3-8-4-2-5/h1-4H,(H,10,11)
InChIKey	BSPHQWQMWIUIPM-UHFFFAOYSA-N
PubChem Compound ID	5300214
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[530900]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 530900	Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. Epub 2010 Apr 13.New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.
Ref 530900	Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. Epub 2010 Apr 13.New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.